白藜芦醇损害与子宫内膜异位症发病机制相关的细胞机制
该体外研究用原代子宫内膜异位症间质细胞、永生化子宫内膜间质细胞(St-T1b)和子宫内膜异位症上皮细胞(12Z)评估白藜芦醇对子宫内膜细胞机制的影响。白藜芦醇显著降低两种细胞系的细胞活力和迁移、增加凋亡细胞数,并降低MMP-2/TIMP-1、VEGF和Ang-1 mRNA表达,同时差异调节干细胞表型标志物。作者结论为白藜芦醇通过差异影响体外子宫内膜和子宫内膜异位症细胞的生长、凋亡、迁移和干细胞表型,对与子宫内膜异位症发展相关的细胞行为发挥抑制作用。
要点
- 白藜芦醇显著降低12Z和St-T1b细胞活力(P=0.0065至P=0.0180)并减少细胞迁移(P<0.001至P=0.0225)。
- 白藜芦醇增加两种细胞系凋亡细胞数(P=0.0031至P=0.0432),并降低MMP-2/TIMP-1、VEGF和Ang-1 mRNA表达。
- 白藜芦醇100 µM升高Notch-1、KLF-4、SOX-2和TERT mRNA表达,对干细胞表型标志物呈差异调节。
核心结论
- 白藜芦醇通过差异影响体外子宫内膜和子宫内膜异位症细胞的生长、凋亡、迁移和干细胞表型,对与子宫内膜异位症发展相关的细胞行为发挥抑制作用。
研究设计与样本
- 体外培养原代子宫内膜异位症间质细胞、永生化子宫内膜间质细胞(St-T1b)和子宫内膜异位症上皮细胞(12Z),评估白藜芦醇对子宫内膜细胞机制的影响。
- 用MTT法评估12Z和St-T1b细胞活力,用FITC Annexin V法和cleaved caspase-3水平评估凋亡,用伤口愈合实验评估细胞迁移。
- 用qRT-PCR评估白藜芦醇对细胞迁移、血管生成和细胞干性相关基因表达的影响。
主要发现
- 白藜芦醇显著降低两种细胞系的细胞活力(P=0.0065至P=0.0180)、细胞迁移(P<0.001至P=0.0225),并增加凋亡细胞数(P=0.0031至P=0.0432)。
- 在细胞系和原代培养中,白藜芦醇降低MMP-2/TIMP-1(P<0.001至P=0.0180)、VEGF(P=0.0052至P=0.0243)和Ang-1 mRNA(P<0.001至P=0.0382)表达。
- 白藜芦醇100 µM在两种细胞系和原代培养中升高Notch-1(P<0.001至P=0.0018)、KLF-4(P=0.0011至P=0.0137)、SOX-2(P<0.001至P=0.0070)和TERT(P<0.001至P=0.0193)mRNA表达水平。
- Snail-1 mRNA表达在细胞系中升高(P<0.001至P=0.0087),OCT-4 mRNA表达在St-T1b(P=0.0396)和原代培养(P=0.0148)中升高;波形蛋白(Vimentin)mRNA表达在原代培养中显著上调(P<0.001)。
- Msi-1(P=0.0145)和NANOG(P=0.0080)表达仅在St-T1b细胞中降低。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does resveratrol exert a potent inhibitory effect on the development of endometriosis by interfering with some pivotal processes? DESIGN: In-vitro cultures of primary endometriotic stromal cells, immortalized endometrial stromal (St-T1b) and endometriotic epithelial (12Z) cells were used to assess the effects of resveratrol on endometrial cell mechanisms. The effects of resveratrol on 12Z and St-T1b cell viability were assessed by MTT assay, apoptosis by FITC Annexin V assay and cleaved caspase-3 levels and cell migration by wound healing assay. The effect of resveratrol on the expression of genes related to cell migration, angiogenesis and cell stemness was evaluated by qRT-PCR. RESULTS: Resveratrol significantly decreased cell viability (P= 0.0065 to P = 0.0180), cell migration (P < 0.001 to P = 0.0225) and increased the number of apoptotic cells (P = 0.0031 to P = 0.0432) in both cell lines. In cell lines and primary culture, the treatment reduced MMP-2/TIMP-1 (P < 0.001 to P = 0.0180), VEGF (P = 0.0052 to P = 0.0243) and Ang-1 mRNA (P < 0.001 to P = 0.0382) expression. Among the stem cell phenotype markers, resveratrol 100 µM increased mRNA expression levels of Notch-1 (P < 0.001 to P = 0.0018), KLF-4 (P = 0.0011 to P = 0.0137), SOX-2 (P < 0.001 to P = 0.0070) and TERT (P < 0.001 to P = 0.0193) in both cell lines and primary cultures. The mRNA expression level of Snail-1 increased in the cell lines (P < 0.001 to P = 0.0087), whereas OCT-4 mRNA expression increased in St-T1b (P = 0.0396) and primary cultures (P = 0.0148). Vimentin mRNA expression showed a significant upregulation in primary cultures (P < 0.001). The expression of Msi-1 (P = 0.0145) and NANOG (P = 0.0080) decreased only in St-T1b cells. CONCLUSION: Resveratrol showed inhibitory effects on cell behaviour related to the development of endometriosis by differentially affecting growth, apoptosis, migration and stem cell phenotype of endometrial and endometriotic cells in vitro.
引用
- Madanes D, Meresman G, Valla SA, et al. Resveratrol impairs cellular mechanisms associated with the pathogenesis of endometriosis. Reprod Biomed Online. 2022. PMID: 35361545. doi:10.1016/j.rbmo.2022.02.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。